A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors
Clinical trial NCT05830045 · UNKNOWN
Trial details
- NCT number
- NCT05830045
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-19
- Primary completion
- 2025-04-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.